Qiagen News
Most Popular Qiagen Story
Qiagen acquires Genaco in $40M deal
Qiagen has acquired Huntsville, AL-based Genaco Biomedical Products for $22 million in cash plus shares. The deal also includes up to $18 million in milestone payments. The deal gives Qiagen ownership of Genaco's expertise in multiplexing technology for diagnostics work. In multiplexing, a diagnostic test screens for more than 10 targets when patients present symptoms that could be attributed to a variety of causes. Multiplexing, for example, could be used to test for hospital acquired …
... Read more...Latest Headlines
- November 18, 2009
- October 2, 2008
- March 7, 2008
- October 29, 2006
- May 3, 2006
- January 3, 2006
- September 28, 2005
- August 3, 2005
- July 31, 2005
- July 6, 2005
- June 29, 2005
- June 8, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
